Selected research
Industry Research
Antibody Expression Service Industry Research Report 2026
Market perspective
The global Antibody Expression Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Antibody Expression Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Antibody Expression Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Antibody Expression Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Antibody Expression Service include GenScript, Thermo Fisher Scientific, Creative Biolabs, ProSci, Curia, Abcam, Wuxi Biologics Co., Ltd., Agilent and Sino Biological, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Antibody Expression Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Antibody Expression Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antibody Expression Service Market by Company
GenScript
Thermo Fisher Scientific
Creative Biolabs
ProSci
Curia
Abcam
Wuxi Biologics Co., Ltd.
Agilent
Sino Biological
Bio-Rad Laboratories
Abzena
Celonic AG
Biomatik
Hangzhou Clongene Biotech Co., Ltd.
Biointron Biological Inc.
Guangzhou Huijun Biotechnology Co., Ltd.
Antibody Expression Service Segment by Type
Monoclonal Antibody Expression
Double Antibody Expression
Polyclonal Expression
Recombinant Protein Expression
Antibody Expression Service Segment by Application
Biomedicine
Clinical Diagnosis
Immunotherapy
Others
Antibody Expression Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Expression Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Expression Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Expression Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Antibody Expression Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal Antibody Expression
- Double Antibody Expression
- Polyclonal Expression
- Recombinant Protein Expression
Applications
- Biomedicine
- Clinical Diagnosis
- Immunotherapy
- Others
Companies covered
- GenScript
- Thermo Fisher Scientific
- Creative Biolabs
- ProSci
- Curia
- Abcam
- Wuxi Biologics Co., Ltd.
- Agilent
- Sino Biological
- Bio-Rad Laboratories
- Abzena
- Celonic AG
- Biomatik
- Hangzhou Clongene Biotech Co., Ltd.
- Biointron Biological Inc.
- Guangzhou Huijun Biotechnology Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Antibody Expression Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Monoclonal Antibody Expression
- 2.2.3 Double Antibody Expression
- 2.2.4 Polyclonal Expression
- 2.2.5 Recombinant Protein Expression
- 2.3 Antibody Expression Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biomedicine
- 2.3.3 Clinical Diagnosis
- 2.3.4 Immunotherapy
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Antibody Expression Service Breakdown Data by Type
- 3.1 Global Antibody Expression Service Historic Market Size by Type (2021-2026)
- 3.2 Global Antibody Expression Service Forecasted Market Size by Type (2027-2032)
4 Antibody Expression Service Breakdown Data by Application
- 4.1 Global Antibody Expression Service Historic Market Size by Application (2021-2026)
- 4.2 Global Antibody Expression Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Antibody Expression Service Market Perspective (2021-2032)
- 5.2 Global Antibody Expression Service Growth Trends by Region
- 5.2.1 Global Antibody Expression Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Antibody Expression Service Historic Market Size by Region (2021-2026)
- 5.2.3 Antibody Expression Service Forecasted Market Size by Region (2027-2032)
- 5.3 Antibody Expression Service Market Dynamics
- 5.3.1 Antibody Expression Service Industry Trends
- 5.3.2 Antibody Expression Service Market Drivers
- 5.3.3 Antibody Expression Service Market Challenges
- 5.3.4 Antibody Expression Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Antibody Expression Service Players by Revenue
- 6.1.1 Global Top Antibody Expression Service Players by Revenue (2021-2026)
- 6.1.2 Global Antibody Expression Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Antibody Expression Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Antibody Expression Service Head Office and Area Served
- 6.4 Global Antibody Expression Service Players, Product Type & Application
- 6.5 Global Antibody Expression Service Manufacturers Established Date
- 6.6 Global Antibody Expression Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Antibody Expression Service Market Size (2021-2032)
- 7.2 North America Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Antibody Expression Service Market Size by Country (2021-2026)
- 7.4 North America Antibody Expression Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Antibody Expression Service Market Size (2021-2032)
- 8.2 Europe Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Antibody Expression Service Market Size by Country (2021-2026)
- 8.4 Europe Antibody Expression Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Antibody Expression Service Market Size (2021-2032)
- 9.2 Asia-Pacific Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Antibody Expression Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Antibody Expression Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Antibody Expression Service Market Size (2021-2032)
- 10.2 South America Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Antibody Expression Service Market Size by Country (2021-2026)
- 10.4 South America Antibody Expression Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Antibody Expression Service Market Size (2021-2032)
- 11.2 Middle East & Africa Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Antibody Expression Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Antibody Expression Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 GenScript
- 12.1.1 GenScript Company Information
- 12.1.2 GenScript Business Overview
- 12.1.3 GenScript Revenue in Antibody Expression Service Business (2021-2026)
- 12.1.4 GenScript Antibody Expression Service Product Portfolio
- 12.1.5 GenScript Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Antibody Expression Service Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Antibody Expression Service Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Creative Biolabs
- 12.3.1 Creative Biolabs Company Information
- 12.3.2 Creative Biolabs Business Overview
- 12.3.3 Creative Biolabs Revenue in Antibody Expression Service Business (2021-2026)
- 12.3.4 Creative Biolabs Antibody Expression Service Product Portfolio
- 12.3.5 Creative Biolabs Recent Developments
- 12.4 ProSci
- 12.4.1 ProSci Company Information
- 12.4.2 ProSci Business Overview
- 12.4.3 ProSci Revenue in Antibody Expression Service Business (2021-2026)
- 12.4.4 ProSci Antibody Expression Service Product Portfolio
- 12.4.5 ProSci Recent Developments
- 12.5 Curia
- 12.5.1 Curia Company Information
- 12.5.2 Curia Business Overview
- 12.5.3 Curia Revenue in Antibody Expression Service Business (2021-2026)
- 12.5.4 Curia Antibody Expression Service Product Portfolio
- 12.5.5 Curia Recent Developments
- 12.6 Abcam
- 12.6.1 Abcam Company Information
- 12.6.2 Abcam Business Overview
- 12.6.3 Abcam Revenue in Antibody Expression Service Business (2021-2026)
- 12.6.4 Abcam Antibody Expression Service Product Portfolio
- 12.6.5 Abcam Recent Developments
- 12.7 Wuxi Biologics Co., Ltd.
- 12.7.1 Wuxi Biologics Co., Ltd. Company Information
- 12.7.2 Wuxi Biologics Co., Ltd. Business Overview
- 12.7.3 Wuxi Biologics Co., Ltd. Revenue in Antibody Expression Service Business (2021-2026)
- 12.7.4 Wuxi Biologics Co., Ltd. Antibody Expression Service Product Portfolio
- 12.7.5 Wuxi Biologics Co., Ltd. Recent Developments
- 12.8 Agilent
- 12.8.1 Agilent Company Information
- 12.8.2 Agilent Business Overview
- 12.8.3 Agilent Revenue in Antibody Expression Service Business (2021-2026)
- 12.8.4 Agilent Antibody Expression Service Product Portfolio
- 12.8.5 Agilent Recent Developments
- 12.9 Sino Biological
- 12.9.1 Sino Biological Company Information
- 12.9.2 Sino Biological Business Overview
- 12.9.3 Sino Biological Revenue in Antibody Expression Service Business (2021-2026)
- 12.9.4 Sino Biological Antibody Expression Service Product Portfolio
- 12.9.5 Sino Biological Recent Developments
- 12.10 Bio-Rad Laboratories
- 12.10.1 Bio-Rad Laboratories Company Information
- 12.10.2 Bio-Rad Laboratories Business Overview
- 12.10.3 Bio-Rad Laboratories Revenue in Antibody Expression Service Business (2021-2026)
- 12.10.4 Bio-Rad Laboratories Antibody Expression Service Product Portfolio
- 12.10.5 Bio-Rad Laboratories Recent Developments
- 12.11 Abzena
- 12.11.1 Abzena Company Information
- 12.11.2 Abzena Business Overview
- 12.11.3 Abzena Revenue in Antibody Expression Service Business (2021-2026)
- 12.11.4 Abzena Antibody Expression Service Product Portfolio
- 12.11.5 Abzena Recent Developments
- 12.12 Celonic AG
- 12.12.1 Celonic AG Company Information
- 12.12.2 Celonic AG Business Overview
- 12.12.3 Celonic AG Revenue in Antibody Expression Service Business (2021-2026)
- 12.12.4 Celonic AG Antibody Expression Service Product Portfolio
- 12.12.5 Celonic AG Recent Developments
- 12.13 Biomatik
- 12.13.1 Biomatik Company Information
- 12.13.2 Biomatik Business Overview
- 12.13.3 Biomatik Revenue in Antibody Expression Service Business (2021-2026)
- 12.13.4 Biomatik Antibody Expression Service Product Portfolio
- 12.13.5 Biomatik Recent Developments
- 12.14 Hangzhou Clongene Biotech Co., Ltd.
- 12.14.1 Hangzhou Clongene Biotech Co., Ltd. Company Information
- 12.14.2 Hangzhou Clongene Biotech Co., Ltd. Business Overview
- 12.14.3 Hangzhou Clongene Biotech Co., Ltd. Revenue in Antibody Expression Service Business (2021-2026)
- 12.14.4 Hangzhou Clongene Biotech Co., Ltd. Antibody Expression Service Product Portfolio
- 12.14.5 Hangzhou Clongene Biotech Co., Ltd. Recent Developments
- 12.15 Biointron Biological Inc.
- 12.15.1 Biointron Biological Inc. Company Information
- 12.15.2 Biointron Biological Inc. Business Overview
- 12.15.3 Biointron Biological Inc. Revenue in Antibody Expression Service Business (2021-2026)
- 12.15.4 Biointron Biological Inc. Antibody Expression Service Product Portfolio
- 12.15.5 Biointron Biological Inc. Recent Developments
- 12.16 Guangzhou Huijun Biotechnology Co., Ltd.
- 12.16.1 Guangzhou Huijun Biotechnology Co., Ltd. Company Information
- 12.16.2 Guangzhou Huijun Biotechnology Co., Ltd. Business Overview
- 12.16.3 Guangzhou Huijun Biotechnology Co., Ltd. Revenue in Antibody Expression Service Business (2021-2026)
- 12.16.4 Guangzhou Huijun Biotechnology Co., Ltd. Antibody Expression Service Product Portfolio
- 12.16.5 Guangzhou Huijun Biotechnology Co., Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst